Patients with risk factors for liver diseases associated with hepatic steatosis constitute the target population for liver fibrosis assessment in primary care

R. HERNÁNDEZ, J. HOYO, M. CAROL, R. NADAL, A. JUANOLA, A. SORIA, A. GARCIA, M. CERVERA, M. PEREZ, M. FUENTES, G. PERA, S. MARTINEZ, C. CHACON, M. SANCHEZ, A. CAPDEVILA, M. ALVAREZ, J. GRATACOS, P. TORÁN, I. GRAUPERA, E. POSE, A. MARTINEZ-ESCUDE, P. GINÈS, L. CABALLERIA and N. FABRELLAS
JOURNAL OF HEPATOLOGY. 2023 Jun 1;

• Any: 01/06/2023
• FI: 26.8
• Article

Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.

Graupera I, Thiele M, Ma AT, Serra-Burriel M, Pich J, Fabrellas N, Caballeria L, de Knegt RJ, Grgurevic I, Reichert M, Roulot D, Schattenberg JM, Pericas JM, Angeli P, Tsochatzis EA, Guha IN, Garcia-Retortillo M, Morillas RM, Hernández R, Hoyo J, Fuentes M, Madir A, Juanola A, Soria A, Juan M, Carol M, Diaz A, Detlefsen S, Toran P, Pera G, Fournier C, Llorca A, Newsome PN, Manns M, de Koning HJ, Serra-Burriel F, Cucchietti F, Arslanow A, Korenjak M, van Kleef L, Falcó JL, Kamath PS, Karlsen TH, Castera L, Lammert F, Krag A and Ginès P
BMC PUBLIC HEALTH. 2023 May 22; . doi:10.1186/s12889-023-15867-6; PMID:37217864

• Any: 22/05/2023
• FI: 3.5
• Article

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study

M. JULIAN, S. BALLESTA, G. PERA, A. DE OCA, B. SOLDEVILA, L. CABALLERIA, R. MORILLAS, C. EXPOSITO, A. MARTINEZ-ESCUDE, M. PUIG-DOMINGO, J. FRANCH-NADAL, P. TORAN, K. CUSI, J. JULVE, D. MAURICIO and N. ALONSO
Frontiers in Endocrinology. 2023 Jan 13; . doi:10.3389/fendo.2022.1051958; PMID:36714592

• Any: 13/01/2023
• FI: 3.9
• Article

Interarm blood pressure difference: Concordance between two methods of automatic simultaneous measurement and between visits reproducibility

N. MARTINEZ-SANCHEZ, A. PALASI, G. PERA, L. MARTINEZ, R. ALBALADEJO and P. TORAN
ATENCION PRIMARIA. 2022 Dec 1; . doi:10.1016/j.aprim.2022.102514; PMID:36423568

• Any: 01/12/2022
• FI: 2.5
• Article

Dysglycemia in young women attenuates the protective effect against fatty liver disease

A. DE OCA, M. JULIAN, G. PERA, L. CABALLERIA, R. MORILLAS, P. TORAN, C. EXPOSITO, J. FRANCH-NADAL, D. MAURICIO and N. ALONSO
Frontiers in Endocrinology. 2022 Nov 21; . doi:10.3389/fendo.2022.971864; PMID:36479218

• Any: 21/11/2022
• FI: 5.2
• Article